Skip to content

13F-HR filed by BRAIDWELL LP

BRAIDWELL LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 88 holding rows worth $2,984,124,707.

Accession
0001420506-23-000696
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 90 entries on the cover page, a total value of $2,984,124,707 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,984,124,707 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC40131MAB5NOTE 11/1250,022,000$156,738,792dollars as filedprincipal
NANOSTRING TECHNOLOGIES INC63009RAD1BOND145,520,000$118,195,691dollars as filedprincipal
NOVOCURE LTD67011XAB9NOTE 11/0131,834,000$117,582,745dollars as filedprincipal
EXACT SCIENCES CORP30063PAC9NOTE 0.375% 3/0139,000,000$109,643,200dollars as filedprincipal
ALPHATEC HLDGS INC02081GAB8NOTE 0.750% 8/0112,250,000$103,135,300dollars as filedprincipal
NEVRO CORP64157FAC7NOTE 2.750% 4/0109,251,000$100,237,793dollars as filedprincipal
GLAUKOS CORP COM377322102Stock1,661,851$72,589,652dollars as filed
IVERIC BIO INC46583P102COM3,341,300$71,537,233dollars as filed
BIOGEN INC COM09062X103Stock252,542$69,933,931dollars as filed
VAXCYTE INC COM92243G108Stock1,362,278$65,321,230dollars as filed
NATERA INC COM632307104Stock1,621,012$65,116,052dollars as filed
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/1141,500,000$63,675,000dollars as filedprincipal
CRINETICS PHARMACEUTICALS INC COM22663K107Stock3,469,674$63,495,034dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock1,548,110$61,041,977dollars as filed
Intuitive Surgical,Inc.46120E602COM223,120$59,204,892dollars as filed
DECIPHERA PHARMACEUTICALS IN24344T101COM3,271,513$53,620,098dollars as filed
KARYOPHARM THERAPEUTICS INC48576UAA4BOND65,976,000$49,369,841dollars as filedprincipal
IONIS PHARMACEUTICALS INC462222AD2NOTE 4/052,740,000$48,949,313dollars as filedprincipal
NEVRO CORP64157F103COM1,192,298$47,215,001dollars as filed
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/150,536,000$46,649,782dollars as filedprincipal
IRHYTHM HOLDINGS INC COM450056106Stock497,667$46,616,468dollars as filed
ALIGN TECHNOLOGY INC COM016255101Stock219,930$46,383,237dollars as filed
OUTSET MEDICAL INC690145107COM1,704,552$44,011,533dollars as filed
AMYRIS INC03236MAJ0BOND137,850,000$43,250,438dollars as filedprincipal
ORTHOPEDIATRICS CORP68752L100COMMON STOCK1,044,699$41,505,891dollars as filed
EXACT SCIENCES CORP30063PAB1NOTE 0.375% 3/148,300,000$40,089,000dollars as filedprincipal
ACLARIS THERAPEUTICS INC COM00461U105Stock2,393,985$37,705,264dollars as filed
INSMED INC457669AA7NOTE 1.750% 1/1399,630,000$37,665,128dollars as filedprincipal
NEOGENOMICS INC64049MAA8Convertible Debt43,000,000$36,469,375dollars as filedprincipal
PENUMBRA INC COM70975L107Stock162,828$36,222,717dollars as filed
Amgen Inc.031162100COM131,100$34,432,104dollars as filed
BELLUS HEALTH INC NEW07987C204COM4,112,494$33,804,701dollars as filed
IONIS PHARMACEUTICALS INC462222AB6NOTE 0.125%12/136,533,000$33,358,282dollars as filedprincipal
LEGEND BIOTECH CORP52490G102SPONSORED ADS658,101$32,852,402dollars as filed
NUVASIVE INC670704AJ4NOTE 0.375% 3/136,665,000$32,210,203dollars as filedprincipal
NEOGENOMICS INC64049MAB6NOTE 0.250% 1/148,678,000$31,947,371dollars as filedprincipal
SYNDAX PHARMACEUTICALS INC87164F105COM1,242,802$31,629,311dollars as filed
MERUS N VN5749R100COM1,998,084$30,910,360dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM1,455,585$30,610,953dollars as filed
TRAVERE THERAPEUTICS INC89422GAA5CNV31,350,000$28,685,250dollars as filedprincipal
KRYSTAL BIOTECH INC COM501147102Stock358,056$28,365,196dollars as filed
HILLEVAX INC43157M102COM1,620,216$27,106,214dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock1,246,539$26,825,519dollars as filed
DICE THERAPEUTICS INC23345J104COM839,075$26,179,140dollars as filed
QUIDELORTHO CORP COM219798105Stock300,437$25,738,438dollars as filed
GLOBUS MED INC CL A379577208Stock343,626$25,521,103dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM1,493,121$23,770,486dollars as filed
ANAPTYSBIO INC032724106COM726,122$22,502,521dollars as filed
SILK ROAD MEDICAL INC82710M100COMMON STOCK416,817$22,028,779dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock3,393,405$21,140,913dollars as filed
BIOMARIN PHARMACEUTICAL INC09061GAK7NOTE 1.250% 5/119,200,000$20,727,568dollars as filedprincipal
APELLIS PHARMACEUTICALS INC03753U106COM389,596$20,146,009dollars as filed
RAPT THERAPEUTICS INC75382E109COM1,000,000$19,800,000dollars as filed
MIRATI THERAPEUTICS INC60468T105COM413,600$18,740,216dollars as filed
TRANSMEDICS GROUP INC89377M109COM303,185$18,712,578dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR49,200$18,638,436dollars as filed
DBV TECHNOLOGIES S A23306J101ADR12,107,785$18,524,911dollars as filed
SAREPTA THERAPEUTICS INC803607100COM140,352$18,186,812dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK662,349$18,015,893dollars as filed
STERIS PLC SHS USDG8473T100Stock95,694$17,673,725dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock235,319$17,557,151dollars as filed
IMMUNOGEN INC45253H101COMMON STOCK3,474,497$17,233,505dollars as filed
THE COOPER COMPANIES216648402COM NEW52,115$17,232,867dollars as filed
INVITAE CORP46185LAB9NOTE 2.000% 9/021,500,000$17,038,830dollars as filedprincipal
NUVASIVE INC670704AL9BOND16,500,000$16,231,875dollars as filedprincipal
Bridgebio Pharma Inc Note 2.250 percent 2/010806XAD4Convertible42,294,000$16,151,021dollars as filedprincipal
ENANTA PHARMACEUTICALS INC29251M106COM325,838$15,157,984dollars as filed
PULMONX CORP745848101COM1,621,494$13,669,194dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,862,700$10,915,422dollars as filed
IMMATICS N.VN44445109SHS1,250,052$10,887,953dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM927,800$10,122,298dollars as filed
BIOMARIN PHARMACEUTICAL INC09061GAH4NOTE 0.599% 8/09,000,000$9,574,200dollars as filedprincipal
VIRIDIAN THERAPEUTICS INC92790C104COM313,403$9,154,502dollars as filed
NKARTA INC65487U108COMMON STOCK1,525,800$9,139,542dollars as filed
COMPASS THERAPEUTICS INC20454B104COM1,814,266$9,125,758dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock753,145$8,728,951dollars as filed
INSMED INC457669AB5NOTE 0.750% 6/010,000,000$8,300,000dollars as filedprincipal
NUVATION BIO INC COM CL A67080N101Stock4,122,900$7,915,968dollars as filed
ALLAKOS INC01671P100COM920,304$7,748,960dollars as filed
ALECTOR INC014442107COMMON STOCK725,024$6,691,972dollars as filed
KODIAK SCIENCES INC50015M109COM914,209$6,545,736dollars as filed
SUPERNUS PHARMACEUTICALS868459AD0BOND6,500,000$6,418,750dollars as filedprincipal
FUSION PHARMACEUTICALS INC36118A100COM2,000,000$6,300,000dollars as filed
Milestone Pharmaceuticals Inc59935V107COM1,164,849$4,612,802dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock381,120$4,001,760dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK258,280$2,910,816dollars as filed
NEKTAR THERAPEUTICS640268108COM620,280$1,401,833dollars as filed
ITEOS THERAPEUTICS INC46565G104COM71,585$1,398,055dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-23-000696this filing2023-02-14acceptance time not in the bulk data set